日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management

更正:第二部分:亚太地区BRCA相关乳腺癌的共识声明和专家建议:临床管理

Park, Yeon Hee; Lee, Soo Chin; Singer, Christian F; Balmaña, Judith; Dent, Rebecca Alexandra; Tan, Veronique Kiak-Mien; Mulansari, Nadia Ayu; Yusof, Mastura Md; Que, Frances Victoria F; Lu, Yen-Shen; Parinyanitikul, Napa; Pham, Cam Phuong; Taib, Nur Aishah; Kong, Sun-Young; Antill, Yoland; Kim, Hee Jeong

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment

第一部分:亚太地区HER2阴性早期乳腺癌的共识声明和专家建议:诊断和风险评估

Lee, Soo Chin; Park, Yeon Hee; Singer, Christian F; Balmaña, Judith; Dent, Rebecca Alexandra; Tan, Veronique Kiak-Mien; Mulansari, Nadia Ayu; Yusof, Mastura Md; Que, Frances Victoria F; Lu, Yen-Shen; Parinyanitikul, Napa; Pham, Cam Phuong; Taib, Nur Aishah; Kong, Sun-Young; Antill, Yoland; Kim, Hee Jeong

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management

第二部分:亚太地区BRCA相关乳腺癌的共识声明和专家建议:临床管理

Park, Yeon Hee; Lee, Soo Chin; Singer, Christian F; Balmaña, Judith; Dent, Rebecca Alexandra; Tan, Veronique Kiak-Mien; Mulansari, Nadia Ayu; Yusof, Mastura Md; Que, Frances Victoria F; Lu, Yen-Shen; Parinyanitikul, Napa; Pham, Cam Phuong; Taib, Nur Aishah; Kong, Sun-Young; Antill, Yoland; Kim, Hee Jeong

Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study

HER2低表达与HER2零表达的HR阳性转移性乳腺癌患者接受内分泌治疗(联合或不联合CDK4/6抑制剂)的临床结局:一项多中心回顾性研究

Susiriwatananont, Thiti; Wongkraisri, Concord; Dajsakdipon, Thanate; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Ithimakin, Suthinee; Dejthevaporn, Thitiya; Parinyanitikul, Napa

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand

比较帕博西尼或瑞博西尼联合AI治疗HR+/HER2-晚期乳腺癌患者的生存疗效(CEPRA研究):来自泰国的真实世界数据的初步分析

Dajsakdipon, Thanate; Susiriwatananont, Thiti; Wongkraisri, Concord; Ithimakin, Suthinee; Parinyanitikul, Napa; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Akewanlop, Charuwan; Dejthevaporn, Thitiya

Genomic medicine and cancer clinical trial in Thailand

泰国基因组医学与癌症临床试验

Thamlikitkul, Lucksamon; Parinyanitikul, Napa; Sriuranpong, Virote

271P Impact of COVID-19 vaccination on health-related quality of life in patients with breast cancer

271P COVID-19疫苗接种对乳腺癌患者健康相关生活质量的影响

Im, S-A; Gennari, A; Park, Y H; Kim, J H; Jiang, Z-F; Gupta, S; Fadjari, T H; Tamura, K; Mastura, M Y; Abesamis-Tiambeng, M L T; Lim, E H; Lin, C-H; Sookprasert, A; Parinyanitikul, N; Tseng, L-M; Lee, S-C; Caguioa, P; Singh, M; Naito, Y; Hukom, R A; Smruti, B K; Wang, S-S; Kim, S B; Lee, K-H; Ahn, H K; Peters, S; Kim, T W; Yoshino, T; Pentheroudakis, G; Curigliano, G; Harbeck, N; Cuesta, P Casado; Díaz, F Pikabea; Galve-Calvo, E; Zumarraga, A; Penas, A Bilbao; De San Vicente, B López; Bejarano, C Figaredo; Pina, I Bernat; Legaspi, J; Galíndez, JR Barceló; Sardina, L Sande; NuÑo Escolastico, M; Abad Villar, MT; Lopez, M; Pérez Hoyos, MT; Sala Gonzalez, MA; Francés, M Temiño; Jaramillo, PL Loaiza; Díaz de Tuesta del Arco, JL; Martinez del Prado, P; Forster, M; Würstlein, R; Koenig, A; Stefan, A; Wiegershausen, E; Mahner, S; Harbeck, N; Chelariu-Raicu, A

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

ChAdOx1-nCoV-19疫苗在实体恶性肿瘤患者中的免疫原性:一项前瞻性多中心观察性研究,比较了不同治疗方案与健康对照组的免疫原性。

Teeyapun, Nattaya; Luangdilok, Sutima; Pakvisal, Nussara; Sainamthip, Panot; Mingmalairak, Siyamol; Poovorawan, Nattaya; Sitthideatphaiboon, Piyada; Parinyanitikul, Napa; Sriuranpong, Virote; Namkanisorn, Teerayuth; Inthasuwan, Pratchaya; Angspatt, Pattama; Wongchanapat, Ploytuangporn; Bamrungnam, Akradach; Leeleakpai, Nutchanok; Uttha, Sutheera; Jaichum, Supaporn; Kongkaew, Peerawich; Suksanong, Chayanin; Veranitinun, Rattiya; Prasomphol, Ampai; Sartsuk, Chada; Patcharajutanon, Cheeraporn; Preaprang, Supreeya; Choengsamor, Hathairat; Phongwan, Rungthong; Preeyasaksa, Charoenpit; Phaibulvatanapong, Ekkamol; Suntronwong, Nungruthai; Yorsaeng, Ritthideach; Vichaiwattana, Preeyaporn; Wanlapakorn, Nasamon; Kerr, Stephen J; Poovorawan, Yong; Wanchaijiraboon, Passakorn; Tanasanvimon, Suebpong

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy

新辅助全身化疗后未达到病理完全缓解的三阴性乳腺癌患者分子亚型的变化

Masuda, Hiroko; Harano, Kenichi; Miura, Sakiko; Wang, Ying; Hirota, Yuko; Harada, Oi; Jolly, Mohit Kumar; Matsunaga, Yuki; Lim, Bora; Wood, Anita L; Parinyanitikul, Napa; Jin Lee, Hee; Gong, Gyungyub; George, Jason T; Levine, Herbert; Lee, Jangsoon; Wang, Xiaoping; Lucci, Anthony; Rao, Arvind; Schweitzer, Brock L; Lawrence, O Rayne; Seitz, Robert S; Morris, Stephan W; Hout, David R; Nakamura, Seigo; Krishnamurthy, Savitri; Ueno, Naoto T

Development and validation of a rapid psychosocial well-being screening tool in patients with metastatic breast cancer

开发和验证一种用于转移性乳腺癌患者的快速心理社会健康状况筛查工具

Thanasansomboon, Bhumipat; Choemprayong, Songphan; Parinyanitikul, Napa; Tanlamai, Uthai; Wisessathorn, Manika; Patarapongsant, Yupin